WHO convenes emergency committee as deadlier Mpox clade spreads across Africa

WHO reasserts authority as global health arbiter; African nations face capacity constraints in outbreak response; potential shift in international health governance priorities toward African disease surveillance; developed nations may increase aid/vaccine diplomacy to contain spread before global transmission.

2022 Mpox pandemic demonstrated rapid global spread despite lower mortality; current Clade 1b's 10x higher lethality mirrors COVID-19 pandemic trajectory concerns—initial regional outbreak becoming international emergency.

Consumers may face increased healthcare costs, travel restrictions, and supply chain disruptions. Potential demand surge for vaccines and medical services could increase out-of-pocket expenses. Travel to affected regions may become costlier or restricted.

Governments likely to increase health surveillance budgets, accelerate vaccine development funding, and potentially implement border health screening. International trade agreements may include health protocols. Insurance regulations may be revised to cover pandemic-related claims.